Machine Perfusion in Liver Transplantation: A Systematic Review and Meta-Analysis

A systematic review and meta-analysis by Jakubauskas et al. aimed to review the literature reporting liver transplant outcomes when using normothermic machine perfusion (NMP) or hypothermic machine perfusion (HMP) for organ preservation compared to static cold storage (SCS). They included 15 studies in the qualitative synthesis (NMP n=6, HMP n=9).  Due to the diversity of the NMP studies, only studies investigative HMP (n=9) were included in the meta-analysis​.

From these studies they found:

  • The potential of NMP to reduce graft injury and lower liver discard rate
  • That HMP reduces
    • Rate of EAD
    • Total biliary complications
    • Non-anastomotic biliary strictures
  • HMP showed a tendency towards improved graft and patient survival at 12-months, though they failed to reach statistical significance

Overall, they concluded that NMP has the potential to reduce graft injury and lower liver graft discard rate. As well as the use of HMP reduces the rate of EAD and non-anastomotic biliary strictures compared to SCS.

Read the full article here: https://www.karger.com/Article/FullText/519788

The Latest

Check out the most recent posts

Katie, Strategic Account Manager

Katie, Strategic Account Manager

My connection to donation and transplantation began with my uncle’s heart transplant in 2002. Since 2011, I’ve served the field through roles in organ procurement, transplant nursing, service line leadership, and industry support for diagnostics and immunosuppressive...

Perspective: One Mission, Many Stories

Author: Virginia Liuti, Strategic Account Manager July 22, 2026As we approach World Organ Donation Day on August 13, I have been reflecting on my own journey in healthcare and how it has shaped the way I see our transplant community. Before joining Organ Recovery...

Ruthanne, Manager, Medical Affairs

Ruthanne, Manager, Medical Affairs

With nearly 30 years of experience in organ transplantation and donation, I joined ORS in April 2024. In my current role as Manager of Medical Affairs, I translate clinical insights into actionable guidance, ensure clear and credible scientific communication across...